25 January 2016

Gernandt & Danielsson advises in Moberg Pharma’s bond issue

Gernandt & Danielsson advises in Moberg Pharma’s issue of corporate bonds amounting to SEK 300 million

The listed pharmaceutical company Moberg Pharma AB (publ) has decided to issue corporate bonds amounting to SEK 300 million through a private placement. The bonds are issued within a framework amount of SEK 600 million. The company has undertaken to list the bonds on Nasdaq Stockholm.

Gernandt & Danielsson has advised the company and its financial advisors Carnegie Investment Bank AB (publ) and Swedbank AB (publ) with a team consisting of Partner Mikael Borg, Senior Associate Adrian Della Morte Pålstam and Associate Katarina Odelberg.

Print